The impact of ECT on TRS patients described above indicates that the clinical improvement of schizophrenia symptoms measured by PANSSs is associated with a reduction in the concentrations of pro-inflammatory markers IL-17, IP-10, and anti-inflammatory IL-10. This evidence concerns the gene CXCL10 and schizophrenia.